A pilot study of accelerated cyclophosphamide, epirubicin and 5-fluorouracil plus granulocyte colony stimulating factor as adjuvant therapy in early breast cancer.

MLA

Del Mastro, L., et al. “A Pilot Study of Accelerated Cyclophosphamide, Epirubicin and 5-Fluorouracil plus Granulocyte Colony Stimulating Factor as Adjuvant Therapy in Early Breast Cancer.” European Journal of Cancer (Oxford, England : 1990), vol. 30A, no. 5, 1994, pp. 606–10. EBSCOhost, https://doi.org/10.1016/0959-8049(94)90529-0.

APA

Del Mastro, L., Garrone, O., Sertoli, M. R., Canavese, G., Catturich, A., Guenzi, M., Rosso, R., & Venturini, M. (1994). A pilot study of accelerated cyclophosphamide, epirubicin and 5-fluorouracil plus granulocyte colony stimulating factor as adjuvant therapy in early breast cancer. European Journal of Cancer (Oxford, England : 1990), 30A(5), 606–610. https://doi.org/10.1016/0959-8049(94)90529-0

Chicago

Del Mastro, L, O Garrone, M R Sertoli, G Canavese, A Catturich, M Guenzi, R Rosso, and M Venturini. 1994. “A Pilot Study of Accelerated Cyclophosphamide, Epirubicin and 5-Fluorouracil plus Granulocyte Colony Stimulating Factor as Adjuvant Therapy in Early Breast Cancer.” European Journal of Cancer (Oxford, England : 1990) 30A (5): 606–10. doi:10.1016/0959-8049(94)90529-0.